Oxaceprol
Clinical data | |
---|---|
Synonyms | (2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic acid |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C7H11NO4 |
Molar mass | 172.159 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Oxaceprol |
Articles |
---|
Most recent articles on Oxaceprol |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Oxaceprol at Clinical Trials.gov Clinical Trials on Oxaceprol at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Oxaceprol
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Oxaceprol Discussion groups on Oxaceprol Directions to Hospitals Treating Oxaceprol Risk calculators and risk factors for Oxaceprol
|
Healthcare Provider Resources |
Causes & Risk Factors for Oxaceprol |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Oxaceprol is an anti-inflammatory drug used in the treatment of osteoarthritis.[1] It is derived from L-proline, a DNA-encoded amino acid. The active effect of Oxaceprol is to inhibit the adhesion and migration of white blood cells.
References
- Pages with script errors
- Pages with citations using unsupported parameters
- Template:drugs.com link with non-standard subpage
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Pyrrolidines
- Alcohols
- Drug